Merck to Acquire JSR Life Sciences Chromatography Business
October 19, 2025
Merck has entered into a definitive agreement to acquire the chromatography business of JSR Life Sciences. The deal is intended to expand Merck’s downstream processing portfolio—particularly Protein A chromatography capabilities used to purify monoclonal antibodies and other therapeutic proteins—and is expected to close by the end of Q2 2026, subject to customary conditions.
- Buyers
- Merck
- Targets
- JSR Life Sciences chromatography business
- Sellers
- JSR Life Sciences
- Industry
- Biotechnology
- Location
- Belgium
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Calibre Scientific Acquires msscientific Chromatographie
November 18, 2021
Healthcare Services
Calibre Scientific has acquired msscientific Chromatographie, a Berlin-based distributor of chromatography products and laboratory consumables. The deal expands Calibre's chromatography-focused offering and strengthens its distribution footprint and service capabilities across the DACH region.
-
Calibre Scientific Acquires American Chromatography Supplies (ACS)
June 17, 2024
Healthcare Services
Calibre Scientific has acquired American Chromatography Supplies LLC (ACS), a U.S. supplier of chromatography consumables, expanding Calibre's chromatography product portfolio and distribution capabilities. ACS, founded in 2011, supplies vials, caps, HPLC/GC columns and other lab consumables to pharmaceutical, academic, clinical, food & beverage, and environmental laboratories in the United States.
-
Bruker Corporation Acquires biocrates life sciences ag
June 3, 2025
Biotechnology
Bruker Corporation has acquired biocrates life sciences ag, an Innsbruck, Austria-based leader in mass-spectrometry-based quantitative metabolomics. The deal adds biocrates' metabolomics kits, assays, software and contract research services to Bruker's multiomics strategy, expanding Bruker's MS-based metabolomics and integrated multiomics capabilities. Financial terms were not disclosed.
-
Adicon Holdings Limited to Acquire Crown Bioscience from JSR Life Sciences
January 1, 2025
Healthcare Services
JSR Life Sciences LLC entered into a definitive agreement to transfer Crown Bioscience Inc. to Adicon Holdings Limited. The transaction is expected to close in 2026, subject to customary closing conditions, and will position Crown as a standalone entity under Adicon’s ownership to accelerate translational oncology and precision medicine growth.
-
Sygnature Discovery Acquires NuChem Sciences
August 1, 2023
Biotechnology
UK-based integrated drug discovery CRO Sygnature Discovery has acquired Montreal-headquartered NuChem Sciences, one of North America's largest discovery contract research organisations. The deal expands Sygnature's global footprint and capabilities in medicinal chemistry, DMPK, structural biology and in vitro/in vivo pharmacology, strengthening its position in the North American market.
-
Biosynth Acquires Cambridge Research Biochemicals (CRB)
May 9, 2023
Biotechnology
Biosynth, a Switzerland-based supplier of critical materials to the life science industry, has acquired Cambridge Research Biochemicals (CRB), a UK-based independent producer of custom peptides and antibody tools. The acquisition expands Biosynth's peptide and antibody capabilities in Europe, adding expertise in complex peptide chemistry, fluorescent dye labelling and custom antibody generation to its existing operations.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.